Yahoo Web Search

Search results

1. • HC Wainwright Cuts Cullinan Oncology (NASDAQ:CGEM) Price Target to $28.00

     ETF DAILY NEWS· 4 days ago

     Cullinan Oncology (NASDAQ:CGEM – Free Report) had its target price decreased by HC Wainwright from $29.00 to $28.00 in a report released on Thursday morning, Benzinga reports. HC Wainwright ...

2. • Q2 2024 EPS Estimates for Syros Pharmaceuticals, Inc. Increased by HC Wainwright (NASDAQ:SYRS)

     ETF DAILY NEWS· 6 days ago

     Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Free Report) – Research analysts at HC Wainwright lifted their Q2 2024 EPS estimates for Syros Pharmaceuticals in a research report issued to clients ...

3. • Vanguard Personalized Indexing Management LLC Raises Position in Incyte Co. (NASDAQ:INCY)

     ETF DAILY NEWS· 4 days ago

     Vanguard Personalized Indexing Management LLC boosted its stake in Incyte Co. (NASDAQ:INCY – Free Report) by 30.4% during the fourth quarter, according to its most recent 13F filing with the ...

4. • MEI Pharma (NASDAQ:MEIP) Coverage Initiated at StockNews.com

     ETF DAILY NEWS· 7 days ago

     Equities researchers at StockNews.com began coverage on shares of MEI Pharma (NASDAQ:MEIP – Get Free Report) in a report released on Wednesday. The brokerage set a “buy” rating on the stock.

5. • Small Business - Salisbury Post | Salisbury Post

     The Salisbury Post· 7 days ago

     HONG KONG, SHANGHAI and FLORHAM PARK, N.J., May 17, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that topline and subgroup results from the ESLIM-01 Phase III study of sovleplenib,

6. • Cullinan Oncology (NASDAQ:CGEM) Stock Rating Reaffirmed by Wedbush

     ETF DAILY NEWS· 5 days ago

     Cullinan Oncology (NASDAQ:CGEM – Get Free Report)‘s stock had its “outperform” rating reissued by investment analysts at Wedbush in a research report issued to clients and investors on Thursday ...